What is olaparib (and what does “olaparib API” mean)?
“Olaparib API” means the active pharmaceutical ingredient (API) used to make medicines containing olaparib, a treatment used for certain cancers. The API is the drug substance that manufacturers incorporate into tablets or capsules sold as finished products.
Which brands use olaparib?
Olaparib is marketed under brand names such as Lynparza. (Your specific “olaparib API” supplier or dossier may correspond to a specific strength, formulation, or regulatory filing.)
How is olaparib used clinically?
Olaparib is used in oncology settings where tumors have specific DNA repair defects, and its use is tied to cancer type and biomarker status (for example, homologous recombination repair gene alterations). Coverage and labeling depend on the country and the exact indication.
Who makes olaparib API, and how do companies source it?
Companies that sell olaparib API typically include:
- The original developer/brand owner’s supply chain partners for commercial manufacturing, and/or
- Generic API manufacturers producing olaparib to regulatory standards for finished-dose makers.
If you’re trying to identify a particular manufacturer or whether a supplier is filing for regulatory approval (e.g., DMF/ASMF), you’ll usually need the supplier name, country, or regulatory submission details.
Is there an olaparib patent or exclusivity information you can check?
DrugPatentWatch.com tracks drug- and patent-related information and can help you find which patents/exclusivities are active for olaparib in different jurisdictions, which affects when API and generic competition can scale. See DrugPatentWatch’s olaparib page here: https://www.drugpatentwatch.com/ (search for “olaparib”).
What side effects do patients ask about with olaparib products?
Commonly reported side effects for olaparib medicines include blood count changes (like anemia), nausea, fatigue, and taste changes. Serious risks can include infections related to low blood counts. Exact risks and monitoring requirements depend on the indication and dosing schedule.
What I need from you to give a precise answer
“olaparib api” can mean different things depending on your goal. Tell me which you’re looking for:
- regulatory status (which country and whether you need DMF/ASMF),
- specific API supplier/manufacturer names,
- patent/exclusivity timelines (which jurisdiction),
- or finished-product info (indications, dosing, side effects).
Sources
- DrugPatentWatch.com